Safety of Ferric Carboxymaltose in Heart Failure Patients With Iron Deficiency Across Ferritin Levels, Heart Failure Causes, and Prior Hospitalization Status: A Meta-Analysis

Puntos clave

• Ferric carboxymaltose shows a favorable safety profile in heart failure patients with iron deficiency.
• Patients across various ferritin levels experienced minimal adverse events related to the treatment.
• Meta-analysis conducted across multiple studies to assess the safety and effectiveness of the intervention.
• Findings suggest that ferric carboxymaltose may improve treatment strategies for heart failure patients.